Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chondroitin Sulfate Proteoglycans/metabolism"'
Autor:
Isaac Francos-Quijorna, Marina Sánchez-Petidier, Emily R. Burnside, Smaranda R. Badea, Abel Torres-Espin, Lucy Marshall, Fred de Winter, Joost Verhaagen, Victoria Moreno-Manzano, Elizabeth J. Bradbury
Publikováno v:
Francos-Quijorna, I, Sánchez-Petidier, M, Burnside, E R, Badea, S R, Torres-Espin, A, Marshall, L, de Winter, F, Verhaagen, J, Moreno-Manzano, V & Bradbury, E J 2022, ' Chondroitin sulfate proteoglycans prevent immune cell phenotypic conversion and inflammation resolution via TLR4 in rodent models of spinal cord injury ', Nature Communications, vol. 13, 2933, pp. 1-23 . https://doi.org/10.1038/s41467-022-30467-5
Nature Communications 13(1), 2933 (2022). doi:10.1038/s41467-022-30467-5
Nature Communications, 13:2933, 1-23. Nature Publishing Group
Nature Communications, 13(1). Nature Publishing Group
Nature Communications 13(1), 2933 (2022). doi:10.1038/s41467-022-30467-5
Nature Communications, 13:2933, 1-23. Nature Publishing Group
Nature Communications, 13(1). Nature Publishing Group
Chondroitin sulfate proteoglycans (CSPGs) act as potent inhibitors of axonal growth and neuroplasticity after spinal cord injury (SCI). Here we reveal that CSPGs also play a critical role in preventing inflammation resolution by blocking the conversi
Autor:
Mahdia Benkhoucha, Mashal Claude Ahmed, Dominique Baeten, Romain Marignier, Jose Boucraut, Olivier Casez, Michael Hahne, Jean Boutonnat, Corinne Sonrier, Benoit Manfroi, Laurie Baert, Patrice N. Marche, Nathalie Sturm, Marine Tessier, Patrice H. Lalive, Romain R. Vivès, Bertrand Huard, Cyril Rivat, Catherine Ghezzi, Hans Lassmann, Pascal Schneider, Natalia Popa, Gilda Raguenez, Alexis Broisat, Hugues Lortat-Jacob, Mitra Ahmadi
Publikováno v:
Annals of Neurology
Annals of Neurology, Wiley, 2019, 85 (3), pp.406-420. ⟨10.1002/ana.25415⟩
Annals of neurology, vol. 85, no. 3, pp. 406-420
Annals of neurology, 85(3), 406-420. John Wiley and Sons Inc.
Annals of Neurology, 2019, 85 (3), pp.406-420. ⟨10.1002/ana.25415⟩
Annals of Neurology, Wiley, 2019, 85 (3), pp.406-420. ⟨10.1002/ana.25415⟩
Annals of neurology, vol. 85, no. 3, pp. 406-420
Annals of neurology, 85(3), 406-420. John Wiley and Sons Inc.
Annals of Neurology, 2019, 85 (3), pp.406-420. ⟨10.1002/ana.25415⟩
International audience; OBJECTIVE:The two related tumor necrosis factor members a proliferation-inducing ligand (APRIL) and B-cell activation factor (BAFF) are currently targeted in autoimmune diseases as B-cell regulators. In multiple sclerosis (MS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64212102082e58fcca9193ce04f096a3
https://www.hal.inserm.fr/inserm-02332844
https://www.hal.inserm.fr/inserm-02332844